EV products obtained from iPSC-derived MSCs show batch-to-batch variations in their ability to modulate allogeneic immune responses in vitro

Mesenchymal stromal cells (MSCs) have demonstrated therapeutic potential in diverse clinical settings, largely due to their ability to produce extracellular vesicles (EVs). These EVs play a pivotal role in modulating immune responses, transforming pro-inflammatory cues into regulatory signals that f...

Descripción completa

Detalles Bibliográficos
Autores principales: Tertel, Tobias, Dittrich, Robin, Arsène, Pierre, Jensen, Arne, Giebel, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642442/
https://www.ncbi.nlm.nih.gov/pubmed/37965578
http://dx.doi.org/10.3389/fcell.2023.1282860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642442/
https://www.ncbi.nlm.nih.gov/pubmed/37965578
http://dx.doi.org/10.3389/fcell.2023.1282860

Ejemplares similares